Biotechnology firm Amyris Inc. argued before a Delaware bankruptcy judge on January 24, 2024 that in order for it to successfully navigate its Chapter 11 case, it must thwart possible equity holder lawsuits. The future success of the company relies on this critical measure, to not only survive but thrive beyond bankruptcy.
It is important for law firms and corporations alike to remain abreast of developments like these. Legal outcomes can set important precedents, thus shaping corporate strategy and dictating how corporations handle similar situations in the future. Keeping a keen eye on these developments ensures staying competitive in their spheres.
For more detailed information regarding this unfolding litigation and what it means for Amyris Inc., please follow this link.